Stock screenerAll disclosures →
EDGAR →
VERU
Conviction 61HealthcareScan · Mon, Aug 10, 2026VERU$2.78+19.10%
ResistanceSupportVol 14Vol MA14 358.7K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price2.78
Change+19.10%
Gap+2.79%
Rel volume8.84×
Avg volume321.55K
Avg $ vol789.59K
SMA 202.32
SMA 502.70
SMA 2002.52
Price vs 50+2.87%
Price vs 200+10.14%
MA stackbullish
50/200 cross—
Supertrendup · 2.07
RSI (14)63
MACD hist0.05
MACD crossbull · 4d
Stoch %K / %D85 / 70
ADX (14)19
+DI / −DI34 / 12
RSI divergenceBullish
MACD divergenceBullish
ATR %+6.88%
ADR %6.51%
52w high4.43
52w low0.3727
From 52w high-37.36%
Above 52w low+644.57%
New 52w highNo
SqueezeFired
Bollinger width20.20%
%B1.46
Donchian pos85.42%
Donchian high2.88
Donchian low2.16
AVWAP (52w high)4.19
vs AVWAP high-33.83%
AVWAP (52w low)3.92
vs AVWAP low-29.18%
OBV trendUp
Chaikin MF (20)0.00
Today vs 20d8.84×
Avg vol (14d)358.7K
Avg vol (20d)321.55K
Avg $ vol (20d)789.59K
Market cap—
RS 3m (vs SPY)-3.50%
RS 6m (vs SPY)-10.10%
RS line new highNo
Trend template3/8
Technical rank74.8
1 week+22.79%
1 month-0.18%
3 months+23.88%
6 months+18.59%
1 year+643.77%
YTD+22.25%
P/E-1.64
P/B1.07
P/S2.20
P/FCF-1.24
EPS-1.10
Div yield0.01%
ROE-65.33%
ROA-52.75%
Debt/Eq0.05
Current6.19
EV/EBITDA-0.46
Gross margin34.67%
Net margin-134.58%
Rev growth3.62%
EPS growth39.88%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value11.26M
Revenue0
Net income-2.74M
Gross profit1.34M
Free cash flow-30.04M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out16.05M
Employees20
ListedFri, Jun 1, 1990
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction61 / 100
Pattern quality—
Tech rank74.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance2.87
Support2.20
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in VERU
No recent disclosed trades by Congress in VERU. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in VERU · 8 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
FISCH HARRY Chief Corporate Officer · Common Stock Option · 2026-05-04 | Grant | 160K | $0 | 2026-05-04 | 2026-05-06 |
STEINER MITCHELL SHUSTER President and CEO · Common Stock Option · 2026-05-04 | Grant | 604K | $0 | 2026-05-04 | 2026-05-06 |
Hyun Grace Director · Common Stock Option · 2026-05-04 | Grant | 97K | $0 | 2026-05-04 | 2026-05-06 |
Lu Lucy Director · Common Stock Option · 2026-05-04 | Grant | 104K | $0 | 2026-05-04 | 2026-05-06 |
Rankowitz Michael L Director · Common Stock Option · 2026-05-04 | Grant | 100K | $0 | 2026-05-04 | 2026-05-06 |
Greco Michele Chief Admin Officer and CFO · Common Stock Option · 2026-05-04 | Grant | 164K | $0 | 2026-05-04 | 2026-05-06 |
Katzovitz Loren Mark Director · Common Stock Option · 2026-05-04 | Grant | 102K | $0 | 2026-05-04 | 2026-05-06 |
BARNETTE K GARY Chief Scientific Officer · Common Stock Option · 2026-05-04 | Grant | 160K | $0 | 2026-05-04 | 2026-05-06 |
SEC filings
EDGAR filings in VERU · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.